These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis. Hou J; Ma T; Cao H; Chen Y; Wang C; Chen X; Xiang Z; Han X J Cell Physiol; 2018 Mar; 233(3):2409-2419. PubMed ID: 28731277 [TBL] [Abstract][Full Text] [Related]
43. M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis. Hou J; Shi J; Chen L; Lv Z; Chen X; Cao H; Xiang Z; Han X Cell Commun Signal; 2018 Nov; 16(1):89. PubMed ID: 30470231 [TBL] [Abstract][Full Text] [Related]
44. The role of high mobility group box1 in pulmonary fibrosis. Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281 [TBL] [Abstract][Full Text] [Related]
45. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663 [TBL] [Abstract][Full Text] [Related]
46. Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis. Lin C; von der Thüsen J; Daalhuisen J; ten Brink M; Crestani B; van der Poll T; Borensztajn K; Spek CA Mol Med; 2015 Jun; 21(1):576-83. PubMed ID: 26147947 [TBL] [Abstract][Full Text] [Related]
47. WNT/β-catenin signaling induces IL-1β expression by alveolar epithelial cells in pulmonary fibrosis. Aumiller V; Balsara N; Wilhelm J; Günther A; Königshoff M Am J Respir Cell Mol Biol; 2013 Jul; 49(1):96-104. PubMed ID: 23526221 [TBL] [Abstract][Full Text] [Related]
48. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis. Lehmann M; Buhl L; Alsafadi HN; Klee S; Hermann S; Mutze K; Ota C; Lindner M; Behr J; Hilgendorff A; Wagner DE; Königshoff M Respir Res; 2018 Sep; 19(1):175. PubMed ID: 30219058 [TBL] [Abstract][Full Text] [Related]
50. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Adamson IY; Bowden DH Am J Pathol; 1974 Nov; 77(2):185-97. PubMed ID: 4141224 [TBL] [Abstract][Full Text] [Related]
51. The anti-fibrotic effect of inhibition of TGFβ-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent γ-herpesvirus infection. Smoktunowicz N; Alexander RE; Franklin L; Williams AE; Holman B; Mercer PF; Jarai G; Scotton CJ; Chambers RC Dis Model Mech; 2015 Sep; 8(9):1129-39. PubMed ID: 26138704 [TBL] [Abstract][Full Text] [Related]
53. miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways. Ge L; Habiel DM; Hansbro PM; Kim RY; Gharib SA; Edelman JD; Königshoff M; Parimon T; Brauer R; Huang Y; Allen J; Jiang D; Kurkciyan AA; Mizuno T; Stripp BR; Noble PW; Hogaboam CM; Chen P JCI Insight; 2016 Dec; 1(20):e90301. PubMed ID: 27942594 [TBL] [Abstract][Full Text] [Related]
54. Precision-cut lung slices from bleomycin treated animals as a model for testing potential therapies for idiopathic pulmonary fibrosis. Cedilak M; Banjanac M; Belamarić D; Paravić Radičević A; Faraho I; Ilić K; Čužić S; Glojnarić I; Eraković Haber V; Bosnar M Pulm Pharmacol Ther; 2019 Apr; 55():75-83. PubMed ID: 30776489 [TBL] [Abstract][Full Text] [Related]
55. Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients. Bondue B; Castiaux A; Van Simaeys G; Mathey C; Sherer F; Egrise D; Lacroix S; Huaux F; Doumont G; Goldman S Respir Res; 2019 Jan; 20(1):10. PubMed ID: 30646908 [TBL] [Abstract][Full Text] [Related]
56. Temporal and spatial characterization of mononuclear phagocytes in circulating, lung alveolar and interstitial compartments in a mouse model of bleomycin-induced pulmonary injury. Ji WJ; Ma YQ; Zhou X; Zhang YD; Lu RY; Sun HY; Guo ZZ; Zhang Z; Li YM; Wei LQ J Immunol Methods; 2014 Jan; 403(1-2):7-16. PubMed ID: 24280595 [TBL] [Abstract][Full Text] [Related]